CAROLINA REGIONAL CANCER CENTER ANNOUNCES CONSTRUCTION OF ITS TOMOTHERAPY PROJECT
843-449-9415 email jcwakefield@CRCCmd.com
Steve Rushton, Preconstruction Services
843-280-3210 email email@example.com
FEBRUARY 28, 2008 Myrtle Beach, SC – Carolina Regional Cancer Center (CRCC) MUSC Hollings Cancer Center and Landmark Builders of South Carolina (Landmark) jointly announce the signing of a construction contract for the completion of CRCC’s TomoTherapy project. Construction began December 17th, 2007 and is expected to be completed in June of 2008.
“Landmark is excited to have been selected to work with CRCC on this important healthcare project. It is a complex project involving the addition and renovation of approximately 6,000 square feet to include the construction of a 600 square foot concrete vault which will be the TomoTherapy treatment room” stated Glenn Williams, Vice President Landmark. “CRCC has the reputation of offering state of the art cancer care to its patients and this project will add to their reputation” he continued.
“We selected Landmark based on a competitive bid and their impeccable reference from a national recognized hospital. We have been impressed with the people of Landmark; their willingness to do what it takes to stay on time, on budget and get the job done right”, declared Collins Wakefield, Chief Financial Officer CRCC. “We started the planning and regulatory process to bring TomoTherapy to Horry County and the surrounding area over three years ago. Our architectural firm, Carter Architecture, has been helping us with the design every step of the way. The addition will be very beneficial to all area cancer patients” he stated.
“TomoTherapy is an exciting relatively new treatment platform that will allow us to treat a number of cancer patients that are presently not treatable. For many patients, TomoTherapy offers a better treatment option than conventional therapy as it better targets the tumor thus sparing more normal tissue which should result in fewer side effects”, commented Dr. Steve Andrews.
CRCC and MUSC Hollings Cancer Center are continuing their joint efforts to broaden the local availability of state-of-the-art cancer treatments.
About Carolina Regional Cancer Center
Carolina Regional Cancer Center is a health care facility that provides comprehensive radiation treatment services. The Center has been providing high quality cancer care for over twenty-eight years. The state of the art center is located at 4708 Oleander Drive, Myrtle Beach, S.C. It is staffed by four physicians—R. Steve Bass, MD, Clinical Director, Assistant Clinical Professor of Radiation Oncology at Medical University of South Carolina and Vanderbilt University Medical Center trained, Todd Williams, MD, Assistant Clinical Professor of Radiation Oncology at MUSC, Paul G. Goetowski, MD, Associate Clinical Professor at Medical College of Georgia in Augusta and Assistant Clinical Professor at MUSC, and Stephen F. Andrews, D.O., Assistant Clinical Professor at MUSC and a graduate from the prestigious Fox Chase Cancer Center in Philadelphia. Dr. Bass also serves on the Hollings Cancer Citizens’ Advisory Board. For additional information regarding CRCC, please see our website www.CRCCmd.com.
About the Hollings Cancer Center
Hollings offers state-of-the-art diagnostic capabilities, therapies and surgical techniques and has multidisciplinary clinics that involve surgeons, medical oncologists, radiation therapists, radiologists, pathologists, psychologists and many other specialists seeing patients simultaneously under one roof. Multidisciplinary care is provided in disease specific clinics such as thoracic, breast, head & neck, genitourinary, gastrointestinal, hematologic, neuro, and pediatric cancers. In 2004 the HCC diagnosed and/or treated more than 1,947 new cancer patients, the largest cancer care provider in the state.
The Hollings Cancer Center is the largest academic-based cancer program in South Carolina. The Hollings Cancer Center is currently funded as a developing National Cancer Institute designated cancer center and has more than $33M in cancer research funding. More than 1,000 people are currently participating on a cancer clinical trial at Hollings.
MUSC Hollings Cancer Center has established the Clinical Trials Network to contract with private cancer care providers to further expand its clinical trial program. Network members are allowed access to MUSC HCC clinical trials; they are provided support for clinical trial operations, oversight and monitoring of the conduct of the trial. The Clinical Trials Network is a collaborative effort with private practices to broaden the reach of new research that may one day be the new standards of care.
About Landmark Builders of South Carolina
Landmark Builders, with offices in North Myrtle Beach and Winston-Salem, NC has a solid history of delivering exemplary general construction services to its customers. Their portfolio of work includes Healthcare, Office, Retail, Resort, High-Rise, Institutional, Distribution, Interior Upfits and Renovations, and Design-Build services.